From a single formulation to a full critical-care injectable portfolio — our focus has stayed the same: reliability, precision, and compliance.
Medella Biotech was founded to address a simple but critical need: consistent, high-quality injectable formulations for hospitals and institutions across India. Critical care doesn't leave room for variability — so every formulation we manufacture is held to the same standard, batch after batch.
Today, we supply a focused range of antibiotic and critical-care injectables — including carbapenems, cephalosporins, and beta-lactam combinations — to hospitals, distributors, and institutional buyers across the country. Every decision we make, from raw material sourcing to final dispatch, is guided by one question: would we trust this in a critical moment for someone we love?
No formulation leaves our facility without passing full quality control — no exceptions, no shortcuts, regardless of order size or urgency.
We commit to consistent availability and honest communication — if there's ever a supply concern, our partners hear it from us first, not last.
Full, continuous compliance with Schedule H/H1 and institutional supply norms — documentation is never an afterthought, it's built into the process.
Every claim we make about a formulation is backed by testing and documentation — no shortcuts, no exceptions.
From formulation to final packaging, precision is non-negotiable — because the people at the other end are patients.
We work closely with hospitals and distributors to make sure supply is dependable, not just promised.
